Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
Investor Type Investor Stage Number of Exits
LinkedIn View on LinkedIn
phillip frost is the Chairman at OPKO Health .
Overview
Personal Investments
Announced Date | Organization Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|
 Eloxx | Series C - Eloxx | |||
Eloxx | Series C - Eloxx | |||
 MabVax Therapeutics | Post-IPO Equity - MabVax Therapeutics | |||
 5to1 | Venture Round - 5to1 |
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Fabrus |  OPKO Health | Venture Round - Fabrus | |||
 NLT SPINE |  Peregrine Ventures | Venture Round - NLT SPINE |
Exits
- MabVax Therapeutics
MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies. - Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates. 
5to15to1 is an online ad publishing platform enabling media publishers to manage and sell their ad space inventory.
Zebra BiologicsCo-Founder
Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
 IVAX Corporation | |||
 The Frost Group | |||
OPKO Health |
Board and Advisor Roles
University of MiamiMember of the Board of Trustees 
Castle BrandsDirector 
OPKO HealthChairman of the Board of Directors - Castle Brands
Member of the Board of Directors
Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
 Teva Pharmaceuticals | |||
IVAX Corporation | |||
 Biozone Pharmaceuticals | |||
 Asensus Surgical | |||
 Ladenburg Thalmann | |||
Teva Pharmaceuticals |
